StayCurrentMD · Prevention of Parenteral Nutrition-associated Cholestasis Using Reduced Dose Soybean Lipid Emulsion: A Multicenter Randomized Trial
Article1 min read·Published Mar 2024Older

Prevention of Parenteral Nutrition-associated Cholestasis Using Reduced Dose Soybean Lipid Emulsion: A Multicenter Randomized Trial

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Mar 2024 · 1 min read

In brief

In brief

This multicenter randomized trial investigates whether reducing soybean lipid emulsion dosage in parenteral nutrition prevents cholestasis while maintaining adequate growth and neurodevelopmental outcomes in pediatric patients. The study addresses a critical balance between preventing liver complications and ensuring sufficient nutritional support.

Written by the GCMD Library team from the article.

Reducing soybean lipid emulsion (SLE) dose may prevent parenteral nutrition-associated cholestasis (PNAC) but effects on growth and neurodevelopment are unknown. The purpose of this study was to evaluate the effect of reduced dose SLE on growth and neurodevelopment.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →